These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Counterfeiting and piracy of pharmaceuticals. Grackin A IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698 [No Abstract] [Full Text] [Related]
6. FDA takes action against firms in scandal over generic products. Pollner F Med World News; 1989 Sep; 30(17):14-5. PubMed ID: 10294736 [No Abstract] [Full Text] [Related]
7. Development of specifications for biotechnology products--perspective from Europe. Trouvin JH Dev Biol Stand; 1997; 91():25-30. PubMed ID: 9413679 [No Abstract] [Full Text] [Related]
8. Quality control and good manufacturing practices: safety and efficacy of commercial herbals. Awang DV Food Drug Law J; 1997; 52(3):341-4. PubMed ID: 10343036 [No Abstract] [Full Text] [Related]
9. Global perspective on specifications for biotechnology products--perspective from Japan. Hayakawa T Dev Biol Stand; 1997; 91():15-23. PubMed ID: 9413678 [No Abstract] [Full Text] [Related]
10. Pharmaceutical products and government policies. Fernandez ST Indian J Ophthalmol; 1988; 36(1):1-2. PubMed ID: 3253190 [No Abstract] [Full Text] [Related]
11. The production process. Drug plant inspection by the food and drug directorate. Smyth JR Med Serv J Can; 1967 Mar; 23(3):270-6. PubMed ID: 6056372 [No Abstract] [Full Text] [Related]
12. Disinfectants as an aid for good manufacturing practice in the pharmaceutical industry. Wallhäusser KH J Pharm Belg; 1981; 36(5):283-97. PubMed ID: 7310623 [No Abstract] [Full Text] [Related]
13. Sales policies intertwine with prescription drug issue. Gloyd J J Am Vet Med Assoc; 1997 Mar; 210(6):735-6, 741-2. PubMed ID: 9074667 [No Abstract] [Full Text] [Related]
14. [Drug committee: TCO will not take a stand on current drug production]. Olofsson C Vardfacket; 1979 Jan; 3(1):74-5. PubMed ID: 253517 [No Abstract] [Full Text] [Related]
15. [Legal basis and significance of manufacturing control in Switzerland]. Fischer P Pharm Acta Helv; 1972; 47(11):629-36. PubMed ID: 4657532 [No Abstract] [Full Text] [Related]
17. Responsible extra-label use of drugs. Cobb DV J Am Vet Med Assoc; 1996 Nov; 209(9):1545. PubMed ID: 8899012 [No Abstract] [Full Text] [Related]
18. [Quality control in herbal supplements]. Oelker L Ann Ist Super Sanita; 2005; 41(1):43-8. PubMed ID: 16037649 [TBL] [Abstract][Full Text] [Related]
19. Supreme Court decision may have major impact on drug industry. Spurgeon D CMAJ; 1993 Feb; 148(4):629-31. PubMed ID: 8431828 [No Abstract] [Full Text] [Related]
20. Regulatory requirements with regard to the use of investigational new drugs. Hodges RM Antimicrob Agents Chemother (Bethesda); 1967; 7():16-8. PubMed ID: 5631922 [No Abstract] [Full Text] [Related] [Next] [New Search]